SpectraScience to Present at the 6th Annual LD Micro Conference

SAN DIEGO, Nov. 25, 2013 (GLOBE NEWSWIRE) -- SpectraScience, Inc. (OTCQB:SCIE), a medical device company utilizing light technologies to detect and diagnose cancers, announced today that Michael P. Oliver, President and CEO, will present at the 6th Annual LD Micro Conference in Los Angeles from December 3rd through 5th, 2013. Mr. Oliver will present a corporate update on Thursday, December 5, 2013 at 10:30 am Pacific.

"We are pleased to have the opportunity to present the SpectraScience story at a quality conference such as LD Micro, and we are looking forward to communicating our exciting prospects to conference attendees," commented Mr. Oliver.

Presentation Information:

Date: Thursday, December 5, 2013

Time: 10:30 am Pacific

Location: Luxe Sunset Bel Air Hotel - Track #4, Los Angeles, CA

Webcast: http://wsw.com/webcast/ldmicro5/SCIE

1x1 Meetings Contact: Michael Oliver (858) 847-0200 x2001

LD Micro Conference:

The LD Micro Conference is a three-day conference organized by LD Micro, an internet-based newsletter that provides self-directed investors information on selected public companies that in the opinion of LD Micro have great investment potential. More than two hundred institutions focused on small and micro-cap stocks are expected to attend. A record 580 people attended the 2012 event. For more information, please visit the conference website at http://www.ldmicro.com/

About SpectraScience, Inc.:

SpectraScience is a San Diego based medical device company that designs, develops, manufactures and markets spectrophotometry systems capable of determining whether tissue is normal, pre-cancerous or cancerous without physically removing tissue from the body. The WavSTAT™ Optical Biopsy System uses light to optically scan tissue and provide the physician with an immediate analysis. With FDA approval for sale in the U.S. and the CE Mark for the European Union, the WavSTAT System is the first commercially available product that incorporates this innovative technology for clinical use.

For more information:

Visit our web site www.spectrascience.com

Forward-Looking Statement for SpectraScience, Inc.

This news release contains forward-looking statements that involve risks and uncertainties that may cause SpectraScience's actual results to differ materially from results discussed in forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by SpectraScience in this news release, its most recent Form 10-K and in SpectraScience's other reports filed with the Securities and Exchange Commission ("SEC") that attempt to advise interested parties of the risks and factors that may affect SpectraScience's business. These forward-looking statements are qualified in their entirety by the cautions and risk factors filed by SpectraScience in its annual report on Form 10-K and other documents.

CONTACT: Media and Investors: SpectraScience, Inc., Lowell Giffhorn, CFO, Phone: (858) 847-0200 x2019 Email: lgiffhorn@spectrascience.comSource:SpectraScience, Inc.